"In accordance with the New York State Department of Health, we are requiring all hospital visitors to follow specific visitation guidelines for the safety of our patients, visitors and team members. Please visit our website to learn more. Northern Westchester Hospital in Mt. Kisco, NY, offers state-of-the-art technology and award-winning patient care. Our specialties include weight loss surgery, cancer treatment, cardiovascular disease, gamma knife and robotic surgery, just to name a few. Our high standards of quality mean NWH ranks among the best hospitals in the country."

During the past decade, Northern Westchester Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Westchester Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Medtronic" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Northwell Health" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Westchester Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Northern Westchester Hospital" are "Breast Cancer" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Northern Westchester Hospital" in a lesser frequency.

Most popular intervention types in "Northern Westchester Hospital" are "Drug" (23 trials), "Other" (21 trials), "Biological" (10 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Placebo" (7 trials), "Quality-of-Life Assessment" (7 trials), "Paclitaxel" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Northern Westchester Hospital" are 28 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Westchester Hospital". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Northern Westchester Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Westchester Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".